Can Neuroticism Be Cured? Why the Better Question Is Whether It Can Change
Updated: Oct 8
Author: Ukrainian Psychological Hub · Published: September 30, 2026 · Editorial Policy
Neuroticism cannot be “cured” in the medical sense because neuroticism is not a disease. It is a dimensional personality trait: a relatively enduring pattern in how readily and intensely a person tends to experience negative emotions, perceive threat, react to stress, and recover from distress. The better scientific question is whether neuroticism can change. The answer is yes. Personality research shows both stability and change across the lifespan, and intervention research shows that neuroticism scores can shift in clinically meaningful and experimentally detectable ways.
That answer still needs a major qualification. A lower score after therapy, a calmer week, reduced anxiety symptoms, or improved mood does not automatically prove that a broad personality trait has permanently changed. Researchers distinguish temporary state fluctuation, symptom improvement, measurement effects, mean-level personality development, individual trait change, and durable change that persists across time and contexts. Those distinctions are the difference between a persuasive claim of “cure” and a scientifically useful account of personality change.
This article owns the cure-language question. For the broader Big Five definition, see Neuroticism: What It Is in the Big Five Personality Model. For the separate question of whether neuroticism is a psychiatric disorder, see Is Neuroticism a Disorder? DSM-5-TR, ICD-11, and Personality Science.
The Short Answer
Neuroticism is changeable, but “curable” is the wrong category. The American Psychological Association describes neuroticism as one of the dimensions of the Big Five personality model, and personality research treats it as a continuum rather than a binary condition that a person either has or does not have. The APA Dictionary of Psychology and the modern research literature therefore give us a trait concept, not a disease entity.
Longitudinal evidence shows that personality traits are relatively stable while still changing across the lifespan. A major meta-analysis found both rank-order stability and systematic mean-level change, including age-related development in emotional stability, the opposite pole of neuroticism Bleidorn et al., 2022. A newer meta-analysis of 229 longitudinal studies involving 230,492 people found significant individual differences in personality change across the lifespan, with neuroticism showing especially pronounced individual variability Haehner et al., 2026.
Intervention evidence points in the same direction. A systematic review of 207 intervention studies found measurable personality-trait change over an average intervention period of about 24 weeks, with emotional stability showing the largest treatment-associated change among the Big Five domains Roberts et al., 2017. In 2026, a systematic review focused on nonclinical neuroticism interventions identified 99 articles and concluded that targeted strategies can produce desired change, while emphasizing that mechanisms and intervention designs remain heterogeneous Wright et al., 2026.
So the evidence supports a precise conclusion: neuroticism is neither fixed nor a medical condition waiting to be eradicated. It is a relatively enduring trait that can move over time and, under some conditions, can be intentionally changed.
Why “Cure” Is the Wrong Model for Neuroticism
The word cure implies a disease model. It usually presupposes an identifiable pathological condition, a treatment directed at that condition, and a meaningful endpoint at which the condition has resolved. Big Five neuroticism does not fit that structure.
In personality science, every person can be located somewhere along the neuroticism–emotional stability dimension. Higher neuroticism generally means a greater tendency toward negative emotionality, worry, distress, threat sensitivity, frustration, self-consciousness, or difficulty recovering after stress. Lower neuroticism generally means greater emotional stability. These are differences of degree. They are not equivalent to “ill” versus “healthy.”
This distinction matters clinically. High neuroticism can be associated with elevated vulnerability to anxiety, depression, and other forms of psychopathology, yet an association is not a diagnosis. A review of the neuroticism–common-mental-disorder relationship concluded that neuroticism is a useful nonspecific risk marker while the causal architecture is complex and compatible with several models, including vulnerability, common-cause, spectrum, state, and scar processes Ormel et al., 2013. A person can score high in neuroticism without meeting criteria for any psychiatric disorder.
The same logic works in the other direction. A person with an anxiety disorder, depressive disorder, OCD, PTSD, or another condition cannot be reduced to “high neuroticism.” Clinical diagnoses are defined by their own criteria, symptoms, duration, impairment, exclusions, and diagnostic context. Personality traits can shape vulnerability and expression without replacing diagnosis.
That is why “How do I cure my neuroticism?” should be translated into a more specific question. Does the person want less frequent worry? Less intense emotional reactivity? Faster recovery after stress? Fewer anxiety or depressive symptoms? Less avoidance? Greater emotional flexibility? A lower score on a particular validated personality measure? These are related goals, but they are not identical outcomes.
Neuroticism Is Relatively Stable, Not Immutable
The phrase “personality trait” often gets misread as “permanent characteristic.” In research, stability means something more technical.
One form is rank-order stability: whether people who score higher than others at one point in time tend to remain relatively higher than others later. Another is mean-level stability: whether the average level of a trait in a population stays the same. A third question concerns individual-level change: whether a particular person moves substantially relative to their own previous level.
These forms of stability can coexist with change. A population can show a mean decrease in neuroticism while many individuals move in different directions. People can preserve much of their relative ranking while everyone shifts somewhat. An individual can change meaningfully even when the population average is stable.
The 2022 longitudinal meta-analysis by Bleidorn and colleagues synthesized evidence across the lifespan and found that personality is both stable and changeable. Rank-order stability generally increases through earlier life and becomes substantial in adulthood, while mean levels of major traits also show systematic development Bleidorn et al., 2022. The 2026 meta-analysis by Haehner and colleagues goes further by showing that people differ significantly in their change trajectories, and that those individual differences remain detectable throughout life Haehner et al., 2026.
This is why a scientific description of neuroticism uses the phrase relatively stable. Relative stability is strong enough for personality traits to predict patterns over time, yet it leaves room for maturation, life experience, changing environments, sustained behavior, clinical treatment, and intentional intervention.
For the lifespan question specifically, Neuroticism and Age: How the Trait Changes Across the Lifespan covers age-related patterns without turning an average developmental trend into a prediction for one person.
What It Actually Means for Neuroticism to Change
A claim that neuroticism “changed” is incomplete unless we specify what changed, how it was measured, for how long, and compared with what.
State fluctuation
People move through emotional states every day. Sleep loss, conflict, illness, deadlines, grief, excitement, caffeine, social context, and countless other factors can alter worry, irritability, sadness, tension, or emotional reactivity for hours or days. Those fluctuations are real, but they are not automatically personality change.
If a person has a calm week after an unusually stressful month, their momentary negative affect may have dropped while their broader trait remains largely unchanged. State measures and trait measures answer different questions.
Symptom change
Clinical symptoms can improve through therapy, medication, environmental change, spontaneous recovery, or other processes. Reduced symptoms may contribute to lower neuroticism scores, especially when personality items overlap in content with distress and negative affect. Yet symptom remission and personality change are not interchangeable outcomes.
This issue has been central to intervention research. In a randomized trial of the Unified Protocol for emotional disorders, participants receiving the intervention showed lower neuroticism at week 16 than participants receiving symptom-focused CBT or a waitlist, and the difference remained after statistically controlling for simultaneous anxiety and depression changes Sauer-Zavala et al., 2021. That strengthens the case that the observed change was not merely a reflection of symptom improvement, while still leaving broader questions about mechanisms and long-term generalization.
Observed score change
A score can change for many reasons: true change in the underlying trait, temporary mood, measurement error, practice or familiarity, changes in self-understanding, response style, social desirability, or shifts in the reference group a person implicitly uses when rating themselves.
Researchers therefore do not infer lasting personality change from one raw score difference in isolation. Repeated assessments, validated instruments, control groups, follow-up measurements, and informant reports strengthen the inference.
Mean-level personality change
Mean-level change refers to shifts in the average trait level of a group. It is useful for developmental and intervention research, but it says nothing certain about any individual participant. An average reduction can arise even when some people change a great deal, some barely change, and some move in the opposite direction.
Individual trait change
Individual change asks whether a particular person shows reliable movement beyond what would be expected from measurement error and ordinary fluctuation. This is conceptually closer to the question people usually mean when they ask, “Can I become less neurotic?”
Durable trait change
The strongest claim is that a change persists after the immediate intervention period, is not explained solely by temporary symptoms or mood, and generalizes across behavior, time, situations, or informants. Few studies can establish every one of these criteria at once. That is why long-term follow-up and multiple measurement methods matter.
What Intervention Research Shows
The overall intervention literature has moved well beyond the idea that personality is untouchable. It has not, however, established a universal recipe for permanently lowering neuroticism in every person.
The 2017 systematic review by Roberts and colleagues remains an important benchmark. Across 207 studies, interventions were associated with changes in personality-trait measures, and emotional stability showed the largest treatment-associated change. Effects were present in experimental as well as nonexperimental designs and persisted in longitudinal follow-up samples Roberts et al., 2017. Because many studies were designed to treat clinical problems rather than personality itself, the review also highlights a persistent interpretive issue: personality measures can change even when personality was not the explicit treatment target.
The 2026 systematic review by Wright and colleagues sharpened the question by focusing on interventions for neuroticism and related constructs in the general public. It reviewed 99 articles and organized intervention components into a taxonomy of strategies, while emphasizing substantial heterogeneity in how interventions were designed and how change mechanisms were conceptualized Wright et al., 2026. The field is therefore increasingly able to say that intentional change is possible, while remaining much less certain about which mechanisms are necessary, sufficient, or optimal for which people.
That difference between “change is possible” and “we know the single best way to produce durable change” is crucial.
Recent Evidence From Targeted Neuroticism Interventions
One of the strongest recent tests comes from a 2026 randomized controlled trial specifically designed to decrease neuroticism in the general public. Wright and colleagues studied 446 German-speaking adults in a six-week smartphone intervention. Across intervention groups, self-reported neuroticism decreased with small-to-moderate effects that persisted at a two-month follow-up, and one of two peer-report measures also showed follow-up effects Wright et al., 2026.
The design is particularly informative because it tested strategies at different levels. State-focused strategies produced larger immediate effects that were less durable, while habit-focused strategies produced smaller initial changes that strengthened over time. Behavior-focused strategies showed especially promising effects across assessment methods. This pattern fits a broader view of personality in which repeated states and habits may accumulate into more enduring trait change.
The findings are important, but they do not establish a universal six-week “cure.” The sample was German-speaking, the follow-up was two months, and peer-report evidence was not uniformly positive across measures. The trial demonstrates experimentally detectable change in a targeted context, not a guaranteed endpoint for every individual.
A larger earlier randomized trial of a digital personality-change intervention studied 1,523 adults who selected desired Big Five change goals. Participants assigned to the intervention changed more in the intended direction than controls, and some observer-rated changes were also detected. Effects persisted to a three-month follow-up Stieger et al., 2021. Again, this supports malleability without implying that every desired personality change is equally easy, equally durable, or equally visible to other people.
Therapy Can Change Neuroticism, but Therapy Is Not a “Cure for a Trait”
Psychotherapy research provides some of the strongest evidence that neuroticism measures can change. That does not mean a person should seek therapy merely because a personality test places them high on neuroticism.
Treatment is usually justified by distress, impairment, a clinical disorder, recurring patterns that interfere with life, or an individually meaningful goal. Neuroticism can be relevant to formulation because it may capture broad tendencies toward negative emotionality and stress sensitivity, yet it is not itself a treatment diagnosis.
The Unified Protocol has been especially important in this literature because it was designed for emotional disorders and explicitly targets processes closely tied to neuroticism and emotion dysregulation. In the randomized study of 223 patients with principal anxiety disorders, the Unified Protocol produced larger reductions in neuroticism than symptom-focused CBT protocols or a waitlist at week 16 Sauer-Zavala et al., 2021.
Later work has tried to determine whether those changes look state-like or trait-like. A small clinical trial found state-level neuroticism changes by session six and evidence consistent with trait-level change by session twelve Stumpp, Southward, & Sauer-Zavala, 2024. A 2026 study of 70 adults with emotional disorders similarly found no significant trait change independent of symptoms during the first six sessions, followed by greater neuroticism reduction during weeks seven through twelve among participants receiving the full treatment Stumpp et al., 2026.
This is a more useful picture than the idea of cure. Treatment can alter recurring emotional and behavioral patterns; sufficiently persistent change in those patterns can be reflected in trait measures; and the distinction between short-term state change and broader trait change becomes clearer with repeated assessment and longer follow-up.
Can CBT Lower Neuroticism?
CBT is a family of interventions rather than one single procedure, and trials differ in population, target, duration, and outcome measurement. The evidence does not justify saying that any course of CBT will automatically lower neuroticism.
The Unified Protocol is CBT-based and transdiagnostic, and trials show that it can reduce neuroticism in treatment-seeking samples. In the 2021 randomized trial, the Unified Protocol produced greater neuroticism reduction than diagnosis-specific, symptom-focused CBT protocols Sauer-Zavala et al., 2021. That finding is especially relevant because it suggests that explicitly targeting broad temperamental and emotional processes may matter.
At the same time, the 2017 intervention meta-analysis found that therapy type was not strongly associated with the amount of personality-trait change across the broader evidence base Roberts et al., 2017. A simple hierarchy in which one named therapy “cures neuroticism” is therefore not supported.
The separate reserved therapy intent in this cluster covers treatment approaches in detail. This article keeps the boundary narrower: therapy can be associated with trait change, but the clinically relevant target remains the person’s symptoms, functioning, patterns, and goals rather than an abstract demand to eliminate a Big Five trait.
Can Medication Cure Neuroticism?
There is no standard medical indication called “high neuroticism” that is treated as though it were an infection, endocrine disorder, or discrete psychiatric diagnosis. Medication decisions are made for specific clinical conditions and patient circumstances.
A person with high neuroticism may also have an anxiety disorder, depressive disorder, OCD, PTSD, or another condition for which medication may be considered according to that condition’s evidence and clinical guidelines. Treating the condition may reduce distress and may also change how a person answers personality items. That does not mean the medication has “cured neuroticism.”
This distinction protects against two common errors. The first is using a personality score as a substitute for diagnosis. The second is interpreting improvement in symptoms during pharmacologic treatment as proof that a broad personality disposition has been medically erased.
Medication questions therefore belong to diagnosis-specific care. The neuroticism construct can provide personality context, but it does not determine a prescription.
Lower Anxiety or Depression Does Not Automatically Mean Lower Trait Neuroticism
Neuroticism overlaps conceptually and statistically with negative emotionality, anxiety, and depression, but the constructs are not interchangeable.
Anxiety can refer to a temporary emotional state, a tendency toward anxiety, a symptom dimension, or a diagnosable anxiety disorder. Depression can refer to mood, symptoms, a screening score, or a depressive disorder. Neuroticism is a broader personality dimension that captures a stable average tendency toward negative emotionality across time and situations.
Because the content overlaps, severe distress can influence self-reported personality scores. This is one reason personality researchers have debated “state artifact” explanations: perhaps an apparent decrease in neuroticism after treatment partly reflects the person no longer being acutely anxious or depressed. Other models propose that treatment actually changes the trait processes that contribute to psychopathology.
The best available evidence suggests both issues matter. The relationship between neuroticism and common mental disorders is complex rather than reducible to a single causal direction Ormel et al., 2013. Intervention studies that measure symptoms and traits repeatedly, use control conditions, and follow participants after treatment offer stronger evidence than a simple before-and-after questionnaire.
For the broader transdiagnostic relationship, Neuroticism and Mental Health: Why the Trait Is a Transdiagnostic Risk Factor separates personality vulnerability from diagnosis.
Measurement Matters: There Is No Universal Neuroticism Score
A claim about change is only as precise as the measurement model behind it.
Different instruments operationalize neuroticism differently. The NEO PI-R and related NEO instruments assess neuroticism within the Five-Factor Model and can provide domain and facet information. The BFI-2 uses the domain label Negative Emotionality and measures anxiety, depression, and emotional volatility facets; its development and psychometric structure are described by Soto and John, 2017. IPIP-based measures vary in length and construction. Eysenck measures come from a different personality tradition and should not be treated as though every raw score maps directly onto a BFI-2 or NEO score.
This means there is no universal number that represents “cured neuroticism.” A raw score of 20 on one instrument can mean something entirely different from 20 on another. A percentile only has meaning relative to the normative sample used to calculate it. A “high” score depends on the scale, scoring method, reference population, and sometimes age or sex norms.
The same caution applies to change. A five-point decline can be large on one scale and trivial on another. Researchers need reliability information, measurement error estimates, repeated measurement, and appropriate norms before deciding whether a change exceeds expected noise.
For instrument-specific interpretation, see Neuroticism Test: What It Measures and How to Interpret Results.
Emotional Stability, Negative Emotionality, and Negative Affect Are Related but Distinct Terms
The language around neuroticism can create the illusion that different measures are interchangeable.
Emotional stability is commonly treated as the low-neuroticism pole of the same broad Big Five dimension. A change toward greater emotional stability can therefore describe the same broad directional movement as a decrease in neuroticism, depending on the instrument and scoring orientation.
Negative Emotionality is the label used for the corresponding Big Five domain in the BFI-2. It overlaps strongly with what many other models call neuroticism, but the labels and facet structures are model-specific.
Negative affect is different again. It usually refers to unpleasant emotional experience, often measured as a state or trait-like affective tendency. Someone can experience a period of high negative affect without having undergone a lasting personality change. A reduction in negative affect during treatment can be clinically valuable while remaining conceptually distinct from a validated change in broad neuroticism.
Keeping those terms separate prevents a common evidence error: taking a study that changed one construct and reporting it as though it proved change in every neighboring construct.
How Researchers Decide Whether Change Is Real
Strong personality-change evidence usually has several features.
First, the study uses a validated measure that matches the construct it claims to measure. Second, it assesses participants more than once. Third, when possible, it includes a comparison or control condition so that ordinary development, regression to the mean, repeated testing, and expectancy effects are less likely to explain the result.
Fourth, stronger studies include follow-up assessments after treatment or intervention ends. Immediate post-treatment change may be important, but persistence is a stronger test of trait change. Fifth, informant or peer reports can add information beyond self-report. A person’s self-perception may shift before other people notice behavioral change, or self-report change may partly reflect demand characteristics.
The 2026 smartphone trial is notable because it combined self-report with peer-report and followed participants after the six-week intervention Wright et al., 2026. The 2021 PEACH trial likewise included observer reports and follow-up, although observer effects were smaller and not uniformly significant for all desired directions of change Stieger et al., 2021.
Sixth, the most informative studies model symptoms and personality at the same time. If anxiety falls and neuroticism falls, researchers can ask whether the trait change remains after accounting for symptom change. That does not solve every causal question, but it is more informative than assuming the two outcomes are identical.
How Much Change Is Enough?
There is no universal clinically meaningful cutoff for a change in neuroticism. Personality scales were not designed as disease tests with a single remission threshold.
Researchers can report standardized effect sizes, reliable-change indices when appropriate, percentile movement, changes relative to controls, or changes in latent trait estimates. Each method answers a different question. A statistically significant group effect can still be modest for an individual. A large individual raw-score change can still be difficult to interpret without reliability and normative information.
A more useful practical question is whether the change is sustained and meaningful in the person’s life. Does the person recover from setbacks faster? Spend less time caught in worry or rumination? React less intensely to minor stressors? Approach situations they previously avoided? Experience less impairment? These behavioral and functional outcomes may matter more than crossing an arbitrary percentile boundary.
This is one reason the goal of personality change is better framed in terms of patterns than a perfect score.
Can Neuroticism Go to Zero?
The idea of zero neuroticism is usually a measurement misunderstanding.
Many neuroticism instruments have minimum possible scores, but the mathematical floor of a questionnaire is not a medical endpoint. Different inventories have different item counts, response formats, scoring rules, facets, and norms. “Zero” on one scale may not even exist on another.
There is also no evidence-based requirement that every person should seek the lowest possible level of neuroticism. Lower neuroticism is associated on average with many favorable outcomes, but personality effects are contextual, and some sensitivity to threat, error, conflict, or potential loss can be useful. The question of costs and possible advantages is addressed directly in Is Neuroticism Good or Bad? Costs, Context, and Possible Advantages.
A scientifically coherent goal is not personality annihilation. It is a level and pattern of emotional responsiveness that supports functioning, relationships, health, and the person’s own values.
Genetics Does Not Mean Fixed
People sometimes hear that neuroticism is heritable and conclude that change must be impossible. That inference confuses heritability with immutability.
Heritability is a population statistic describing the proportion of variation in a trait that is associated with genetic differences under particular environmental conditions. It does not tell us what percentage of one person’s neuroticism is “genetic,” nor does it say that an individual’s trait level cannot change.
A trait can be substantially heritable and still change across development or in response to experience and intervention. The longitudinal and intervention evidence reviewed above is direct evidence of that point. Genetic influence can help explain why people differ; it does not provide a personal destiny score.
For the full causes question, including genetics, temperament, environment, and life experience, see What Causes Neuroticism? Genetics, Temperament, Environment, and Life Experience.
What Lasting Change May Look Like in Everyday Life
Lasting change in neuroticism does not require becoming emotionally flat or never experiencing anxiety, sadness, anger, embarrassment, or fear.
A person who changes toward greater emotional stability may still feel negative emotions when situations warrant them. The difference may appear in frequency, intensity, duration, interpretation, and recovery. Stressors may trigger less catastrophic forecasting. Worry may be less sticky. Emotional reactions may resolve more quickly. Ambiguity may feel less threatening. The person may rely less on avoidance or reassurance and more often continue valued activity despite discomfort.
These examples describe possible manifestations rather than diagnostic criteria. They also show why trait change can emerge gradually from repeated patterns. A personality trait summarizes what a person tends to do, feel, and think across situations. If those recurring states and habits shift consistently, the broader trait estimate can eventually shift with them.
This logic is consistent with the 2026 targeted intervention finding that state-focused strategies produced faster immediate effects while habit-focused strategies showed changes that strengthened over time Wright et al., 2026.
For stress processes specifically, see Neuroticism and Stress: Perceived Stress, Reactivity, and Recovery. For regulation strategies and flexibility, see Neuroticism and Emotion Regulation: Strategies, Flexibility, and Distress.
When the Real Question Is About a Mental Health Condition
Sometimes “Can I cure my neuroticism?” is really a help-seeking question about persistent anxiety, depressed mood, panic, intrusive thoughts, trauma symptoms, health anxiety, insomnia, or another source of distress.
In that situation, the clinically relevant task is to assess the actual symptoms, their duration, severity, functional impact, medical context, and diagnostic possibilities. A personality score can add context, but it cannot diagnose the underlying condition.
This is especially important because neuroticism is transdiagnostic: it is associated with multiple forms of psychopathology rather than uniquely identifying one disorder. Ormel and colleagues describe it as a broad marker of vulnerability whose relationship with common mental disorders reflects several possible causal and noncausal processes.
A high-neuroticism score should therefore never be used as a shortcut to decide that someone “has anxiety,” “has depression,” or needs a particular treatment. Screening results, symptoms, personality traits, and diagnoses are distinct levels of information.
A Better Goal Than “Curing” Neuroticism
The strongest scientific reframing is simple: move from eradication to change.
Instead of asking whether neuroticism can be cured, ask which recurring patterns create the most difficulty and whether those patterns can become more flexible. If the goal is lower stress reactivity, measure stress reactivity. If the goal is less avoidance, examine avoidance. If the goal is a lower trait score, use the same validated instrument under comparable conditions and interpret the difference with its psychometrics and norms.
Intentional personality change also works better as a process than as an identity verdict. “I am neurotic and need to cure myself” turns a dimensional construct into a fixed label. “I tend to react strongly to uncertainty, and I want to become more flexible in those situations” identifies a changeable pattern.
That shift is faithful to modern personality science. Traits summarize tendencies; they do not imprison a person inside a type.
Frequently Asked Questions
Can neuroticism be cured permanently?
Neuroticism is not a disease, so “permanent cure” is not the appropriate scientific endpoint. Research shows that neuroticism can change and that some intervention-associated changes persist after treatment. Long-term durability varies across studies and individuals, and no study can guarantee permanent change for a specific person.
Can neuroticism decrease with age?
On average, emotional stability tends to increase across parts of adulthood, which corresponds to lower neuroticism in models that treat the two as opposite poles. Average developmental trends do not predict every individual trajectory. See Neuroticism and Age: How the Trait Changes Across the Lifespan for the lifespan evidence.
Can therapy lower neuroticism?
Yes, therapy studies have found reductions in neuroticism measures, and a large intervention meta-analysis found emotional stability to be the personality domain showing the largest treatment-associated change Roberts et al., 2017. Therapy is generally indicated by distress, impairment, a clinical condition, or a meaningful treatment goal rather than by a Big Five score alone.
Can CBT lower neuroticism?
Some CBT-based interventions, especially the transdiagnostic Unified Protocol, have reduced neuroticism in randomized clinical research Sauer-Zavala et al., 2021. That does not mean every CBT protocol produces the same effect or that CBT is a standardized “cure” for neuroticism.
Can medication lower neuroticism?
A personality trait is not itself a medication indication. Medications may be used for specific psychiatric conditions that can co-occur with high neuroticism, and personality scores may shift as symptoms change. Treatment decisions should be tied to the clinical condition and the individual rather than to a neuroticism score.
Does a lower neuroticism score prove that treatment worked?
Not by itself. Interpretation depends on the instrument, scoring method, measurement reliability, norms, timing, symptom change, and whether the improvement persists. A single raw-score difference cannot establish durable trait change.
Is neuroticism genetic and therefore permanent?
No. Heritability describes variation in populations and does not mean a trait is immutable in an individual. Longitudinal and intervention studies directly show that neuroticism can change.
Is emotional stability the same as having no negative emotions?
No. Emotional stability describes a lower average tendency toward intense or persistent negative emotional reactivity. Psychologically healthy people still experience fear, sadness, anger, guilt, and other negative emotions when circumstances call for them.
Can someone move from a “high” score to an “average” score?
Possibly, but “high” and “average” are instrument- and norm-dependent. A percentile or category only has meaning within the specific test, normative sample, scoring procedure, and population. There is no universal neuroticism cutoff that all measures share.
How long does neuroticism change take?
There is no universal timeline. Intervention studies have detected change across periods ranging from weeks to months, while lifespan personality development unfolds over years. Recent targeted work has found measurable change within six weeks, but durable change requires follow-up and should not be inferred from one short-term measurement Wright et al., 2026.
Conclusion
Neuroticism can change. That conclusion now rests on converging evidence from lifespan research, intervention meta-analyses, randomized clinical trials, and targeted nonclinical personality-change studies.
The word cure obscures more than it clarifies. Neuroticism is a dimensional personality construct, not a psychiatric disease. People differ in it, and those differences are relatively stable enough to be meaningful while remaining changeable enough to develop across life and respond to sustained intervention.
The scientifically useful questions are therefore about magnitude, mechanism, measurement, durability, and function. Did a person’s recurring emotional patterns change? Was the change larger than ordinary fluctuation or measurement error? Did it persist? Did behavior or informant reports change too? Did symptoms improve independently, together with the trait, or first? Does the change matter in daily life?
Those questions turn “Can neuroticism be cured?” into the question personality science can actually answer: under what conditions, by what processes, and with what durability can neuroticism change?
Related Articles
References
Bleidorn, W., Schwaba, T., Zheng, A., Hopwood, C. J., Sosa, S. S., Roberts, B. W., & Briley, D. A. (2022). Personality stability and change: A meta-analysis of longitudinal studies. Psychological Bulletin, 148(7–8), 588–619. https://doi.org/10.1037/bul0000365
Haehner, P., Hopwood, C. J., Schellenberg, L., Schwaba, T., & Bleidorn, W. (2026). Individual differences in personality trait changes across the lifespan: A meta-analysis of longitudinal studies. Psychological Bulletin, 152(4), 420–447. https://doi.org/10.1037/bul0000525
Lahey, B. B. (2009). Public health significance of neuroticism. American Psychologist, 64(4), 241–256. https://doi.org/10.1037/a0015309
Ormel, J., Jeronimus, B. F., Kotov, R., Riese, H., Bos, E. H., Hankin, B., Rosmalen, J. G. M., & Oldehinkel, A. J. (2013). Neuroticism and common mental disorders: Meaning and utility of a complex relationship. Clinical Psychology Review, 33(5), 686–697. https://doi.org/10.1016/j.cpr.2013.04.003
Roberts, B. W., Luo, J., Briley, D. A., Chow, P. I., Su, R., & Hill, P. L. (2017). A systematic review of personality trait change through intervention. Psychological Bulletin, 143(2), 117–141. https://doi.org/10.1037/bul0000088
Sauer-Zavala, S., Fournier, J. C., Jarvi Steele, S., Woods, B. K., Wang, M., Farchione, T. J., & Barlow, D. H. (2021). Does the Unified Protocol really change neuroticism? Results from a randomized trial. Psychological Medicine, 51(14), 2378–2387. https://doi.org/10.1017/S0033291720000975
Soto, C. J., & John, O. P. (2017). The next Big Five Inventory (BFI-2): Developing and assessing a hierarchical model with 15 facets to enhance bandwidth, fidelity, and predictive power. Journal of Personality and Social Psychology, 113(1), 117–143. https://doi.org/10.1037/pspp0000096
Stieger, M., Flückiger, C., Rüegger, D., Kowatsch, T., Roberts, B. W., & Allemand, M. (2021). Changing personality traits with the help of a digital personality change intervention. Proceedings of the National Academy of Sciences, 118(8), e2017548118. https://doi.org/10.1073/pnas.2017548118
Stumpp, N. E., Southward, M. W., & Sauer-Zavala, S. (2024). Assessing theories of state and trait change in neuroticism and symptom improvement in the Unified Protocol. Behavior Therapy, 55(1), 93–105. https://doi.org/10.1016/j.beth.2023.05.005
Stumpp, N. E., Southward, M. W., Hines, A., Kushner, M. L., Schäuffele, C., Fruhbauerova, M., Bridges, E., Rahman, A., & Sauer-Zavala, S. (2026). When and under what circumstances does neuroticism change in the Unified Protocol? Psychotherapy Research. https://doi.org/10.1080/10503307.2025.2521779
Wright, A. J., Haehner, P., Hopwood, C. J., & Bleidorn, W. (2026). A systematic review and taxonomy of neuroticism interventions for the general public. Personality Science. https://doi.org/10.1177/27000710261421531
Wright, A. J., Haehner, P., Andrae, R., Lubczyk, T., Hopwood, C. J., & Bleidorn, W. (2026). Effects of a theory-based smartphone intervention to decrease neuroticism in the general public. Psychological Science. https://doi.org/10.1177/09567976261476962